Alex Liu is the AD, Clinical Systems at Taiho Oncology, where he leads in‑house EDC study builds and advances data review capabilities to support high‑quality clinical trial execution. His work focuses on CRF standardization and the integration of AI‑driven approaches into scalable workflows that deliver earlier, more actionable insights. Alex drives initiatives to modernize clinical data management through advanced analytics and AI adoption, bridging technical innovation with business needs. He has a strong interest in the evolving role of AI in clinical research.

Amir Momen-Roknabadi is Director of Artificial Intelligence at Therna Biosciences, where he leads the AI team accelerating RNA design and optimization across the therapeutic pipeline. He brings over a decade of experience across machine learning, computational biology, and translational biotechnology, with deep expertise in building end-to-end ML systems that turn complex biological and clinical data into actionable insight.

Prior to Therna, Amir developed RNA-based generative AI models for early cancer detection at Exai Bio, contributing to liquid biopsy approaches validated against clinical cohorts. Amir earned his Ph.D. from Princeton University and completed postdoctoral training at Columbia University, where he developed computational methods to connect biological sequence, structure, and function at scale.

Experienced Consultant with a demonstrated history of delivering clinical IT projects for pharma, biotech/CROs with a Wharton Management Development Program, Kellogg Product Strategy and a Stanford Advanced Program Management from Stanford University. Anand is a tech savvy leader with interests in AI, big data, blockchain and use them to address the challenges faced by the life sciences industry. He is a big believer in product innovation and leads teams in product development. Anand loves participating in hackathons and social innovation activities in the life sciences/ healthcare space.

Biotech executive with 20+ years of experience driving innovation at the intersection of science, medicine, and technology. Currently VP, Head of Translational Medicine at Verge Genomics, where I built the function from the ground up and advanced neurology programs through Phase 2/3 readiness using FDA-validated biomarkers. Previously at Pfizer, I led cross-functional teams delivering novel digital endpoints, secured FDA/EMA alignment, and helped advance Ponsegromab from Phase 1 to Phase 2/3. At Biogen, I drove digital diagnostics initiatives, advanced technologies in Alzheimer’s and stroke, and helped spin out a new venture. I also founded a digital diagnostics startup, Usin’Life, which exited with a few assets. Passionate about advancing therapies for patients with high unmet medical needs, I bring expertise in translational medicine, biomarker strategy (digital & fluid), regulatory engagement, using technology ( including AI/ML !) and partnerships across biotech, pharma, and academia.

Strategic Clinical Development Leader | Oncology & Beyond I am a strategic and science-driven clinical development leader with 16+ years of experience shaping global drug development across oncology (solid tumors & hematologic malignancies), cardiovascular, rare, and specialty medicine. Over my career, I have:

• Directed global Phase I–III trials that informed pivotal approvals and label expansions
• Led NDA/BLA submissions resulting in successful global filings and regulatory milestones
• Built and guided high-performing cross-functional teams spanning Clinical Development, Biostatistics, Safety, Regulatory, and Clinical Operations
• Partnered with KOLs, CROs, and regulators to navigate complex development pathways I’m known for bringing clarity and structure to complexity, aligning science with strategy, and driving decisions that accelerate development while upholding patient focus and data integrity. As a senior leader, I thrive in fast-paced, matrixed environments where strategy, adaptability, and communication define success. I am also deeply committed to mentorship and talent development, ensuring teams grow alongside programs. Specialties: Oncology Clinical Development | Global Regulatory Submissions | Trial Oversight | Medical Monitoring | Portfolio & Pipeline Strategy | Cross-Functional Leadership | Data-Driven Decision Making

Broadly speaking, I am a research professional dedicated to improving access to healthcare services, the development of novel and effective treatments for disease prevention, symptom relief, and cures, and improving the quality of care through a reduction in the occurrence of medical errors. My particular set of skills, acquired through education and experience, have made me adept at working with the data essential to tackling these issues.

Christie is a senior clinical leader at Revvity Signals, bringing over 20 years of experience across life sciences and clinical analytics. She has deep expertise spanning clinical trials, real-world evidence, vaccine development, and genomics, with a career focused on translating complex clinical data into actionable insight. Throughout her work, Christie has helped shape and guide enterprise clinical solutions used across biotechnology and healthcare organizations worldwide.

I lead R&D data enablement and data product strategy, building scalable, governed data foundations that transform data into a strategic asset across the Pharma R&D value chain. I focus on building high-quality, reusable, and interoperable operational data platforms and domain-specific data products that speed scientific outcomes, support advanced analytics and AI/ML, and deliver measurable business value. I work closely with stakeholders across Research, Clinical Development, Safety, Regulatory, and Portfolio & Project Management to ensure R&D data is discoverable, analytics-ready, and fit for decision-making. By applying data product thinking, strong governance, and modern data architecture principles, I help organizations move from siloed data to trusted, scalable, cross-domain insights. Core Competencies: R&D data foundations & data product strategy, Analytics- and AI/ML-ready data enablement, Data governance, Product Management, Clinical Data Management, Data Standards & Analytics, Decentralized Trials (DCT, DHT), Governance & Risk Oversight, AI & Digital Innovation, Stakeholder Management, Data Privacy & Security, Vendor Management, Design Thinking, Leadership Development, Certified Coach Technology, Tools, and Frameworks: Medidata Rave, Oracle Clinical, Veeva Clinical/Vault, Informatica, Reltio, Formedyx, Collibra, Python, VBA, Databricks, AWS Bedrock, UIPath, Redshift, SpotFire, Power BI, GCP, CDISC, 21CFRP11, RBQM, FHIR, CRISP-DM, V3+, LEAN

Erik Scalfaro, is the Co-Founder and CEO of Rivia, a data engine powering clinical trials by unifying all study data into a single intelligence layer.

He brings over 10 years of experience across pharma, clinical analytics, and applied data science. Prior to founding Rivia, Erik held roles at Novartis, IQVIA, and the Swiss Armed Forces, where he worked directly on post-marketing safety surveillance, pivotal registration trials, and exploratory analyses supporting global development programmes.

Erik holds a Master of Medical Science in Health Informatics from Karolinska Institutet, a Master of Science in Data Science from Stockholm University, and a BSc in Neuroscience and Organic Chemistry from University College London.

Jen Manzi is a Subject Matter Expert and User Advocate at Pinnacle 21. She has over 20 years of Pharma/Life Sciences industry experience in Clinical Trials and Safety Data Management. Jen has held various roles within these areas, including eCRF Programmer, SDTM Delivery Lead, Product Owner and Programmer of Batch Processes, Vendor Relationship Manager, Program and Process Improvement Manager, and Validation Lead.

Kevin Tsai is a senior data and analytics leader with over 20 years of experience spanning biotechnology, data/software engineering, and data platforms with companies like Celera, Gilead, and Celgene / Bristol Myers Squibb. He currently leads enterprise data initiatives at Genmab, driving data-as-a-product, data mesh, and modern cloud-based data platforms. Kevin combines engineering expertise with strategic leadership, helping organizations transform complex data management across research, clinical development, and commercial functions. He is passionate about building high-performing teams, advancing data literacy, and creating scalable data ecosystems that accelerate innovation.

I’m a strategic innovation leader passionate about shaping the future through collaboration, foresight, and action, with 10+ years of cross-industry experience leading AI-driven transformation, and idea-incubation programs. At Takeda, I lead cross-functional teams that turn bold ideas into real-world impact. Whether designing AI-augmented solutions, facilitating innovation sprints, or running strategic foresight labs, my mission is to empower people and systems to work smarter, faster, and more meaningfully. In my experience, the key piece of a successful concept-to-launch process is creating focus for the team. This requires continuous prioritizing and fluency in both tech and laypeople speak. I’m genuinely and deeply curious about the subject matter in my care, and it helps me translate ambiguous challenges into bold, scalable solutions, launch enterprise-wide innovation initiatives, and lead high-performing teams to deliver lasting impact. With a background in business analysis, agile coaching, and startup consulting, I thrive at the intersection of creativity, technology, and human-centered design. I’ve launched noteworthy MVPs, guided 60+ innovation champions, and delivered measurable results in complex environments. If you're looking to future-proof your organization, foster a culture of experimentation, and lead with empathy—let’s connect.

Research scientist and team builder specializing in drug discovery, AI/ML, functional genomics, and RNA biology, with experience in clinical development from target identification through patient selection.

Narayan has and ten (10)+ years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward. 

With over 10 years of experience in data sciences, clinical informatics, bioinformatics, and AI-driven analytics, I am a passionate leader and innovator in the clinical and genomics field. As the Director of Data Sciences at Illumina, I leverage advanced technologies to create data-driven solutions that improve patient outcomes and accelerate innovation in the genomics industry. My core competencies include working with real-world data (EHR systems), clinical trial analytics, population genetics workflows, drug target discovery, and multi-modal next-generation sequencing data. I have extensive knowledge and experience in Python, R, SQL, Java, C/C++, Cloud computing (AWS, Azure), and deep learning frameworks. I also have a strong background in software development, database design, and high-performance computing. I enjoy collaborating with cross-functional teams, mentoring aspiring data scientists, and sharing my insights and expertise with the scientific community. My mission is to harness the power of clinical and genomics data and AI/ML to advance precision medicine and healthcare.

Satish Dachepally is an Executive Director at Incyte Corporation focusing on Clinical Data Management areas. Satish has over 20 years of success in overseeing the collection, analysis, and reporting of clinical trial data.  He is adept at implementing industry standards and best practices, including CDISC SDTM and CDASH to ensure data integrity, compliance, and streamlined processes.  He is dedicated leader passionate about advancing clinical research through robust data management practices.  He made significant contributions to successful approval of multiple marketed drugs across diverse indications.  Satish earned a Master of Science degree from United Kingdom.

Scott Robertson is vice president of sales, responsible for driving growth and developing Mednet’s relationships with CROs and other strategic partners. With a strong understanding of the clinical research landscape and the needs of service providers, Scott works closely with partners to identify opportunities, strengthen collaboration, and support long-term success. In his role, he ensures partners receive the concierge-level service Mednet is known for, while helping them uncover new opportunities to expand their capabilities, grow their business, and accelerate clinical development.

As a technology leader and life sciences domain expert, Sriram brings in a unique blend of management capability, end-to-end delivery expertise, consulting, architectural, and analytical skills. His areas of expertise include data science, machine learning, deep learning, big data, cloud services, behavioral sciences, business analytics, predictive analytics, data warehousing, business intelligence, and data management. He specializes in clinical systems, commercial operations, and digital marketing.

Lead project management, monitoring and data management initiatives for 500 projects, using expertise in leadership, analysis, evaluation, resource requirements, and technical tools to increase productivity, and to proactively create contingency plans that resolve significant issues. Extensive global leadership for 80 Biometric professions in the processing of large multi-central trials that achieved NDA/MAA submissions/approvals and post approval requirements, while managing Biometrics department P&L. Key strength areas include: DATA MANAGEMENT | PLANNING | METHODOLOGY EVALUATION | TECHNICAL | GLOBAL TEAM LEADERSHIP | DASHBOARD DEVELOPMENT | CROSS-FUNCTIONAL TEAMS | SOP DEVELOPMENT

Strategic leader with 20+ years in global drug development, driving data governance, AI innovation, and clinical transformation. I specialize in delivering scalable clinical applications and integrated data solutions that strengthen quality, compliance, and operational efficiency across GxP and non‑GxP domains. I’m known for building connected clinical ecosystems, mentoring cross‑functional teams, and aligning digital strategies with real patient impact. My leadership style blends clarity, calm authority, and emotionally intelligent decision‑making — especially in complex, high‑visibility environments. I’ve managed and mentored global teams to deliver multiple large‑scale digital initiatives, modernize clinical data flows, and enable automation that reduces operational burden. I’m focused on roles where I can shape strategy, own domains, and advance healthcare through analytics, automation, and thoughtful, human‑centered leadership.